GlassScriptPhysician profile
Angela B Didyk
NPI 1063611952
$1,078.09
in general payments reported to CMS, 2019-2025
18 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $15.52 · 2021: $132 · 2022: $279 · 2023: $82.54 · 2024: $150 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $367.79 | 2019-2025 | Grafix Pl, Grafix, Stravix |
| Boston Scientific Corporation | $131.14 | 2022 | |
| Pfizer INC. | $123.35 | 2019 | |
| Fusion Orthopedics USA, LLC | $108.74 | 2025 | |
| Organogenesis INC. | $67.82 | 2022-2025 | Affinity, Novachor |
| Sebela Pharmaceuticals INC. | $58.76 | 2022-2023 | Naftin, Pramosone |
| Dynasplint Systems INC. | $35.54 | 2021 | |
| Paratek Pharmaceuticals, INC. | $22.62 | 2022 | |
| Zimmer Biomet Holdings, INC. | $21.70 | 2021 | |
| Paragon 28, INC. | $21.36 | 2021 | |
| Averitas Pharma INC. | $19.67 | 2023 | Qutenza |
| Nabriva Therapeutics, Plc | $15.97 | 2022 | |
| Melinta Therapeutics, LLC | $15.75 | 2021 | |
| Zyla Life Sciences, INC. | $15.52 | 2020 | |
| Medartis INC. | $14.34 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.32 | 2022 | |
| Nevro Corp. | $12.19 | 2021 | |
| Bioventus LLC | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Didyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.